Android app on Google Play

Credit Suisse Starts PDL BioPharma (PDLI) at Neutral

November 13, 2012 6:44 AM EST Send to a Friend
Get Alerts PDLI Hot Sheet
Price: $8.41 +1.94%

Rating Summary:
    1 Buy, 4 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 9 | New: 22
Trade PDLI Now!
Join SI Premium – FREE
Credit Suisse initiates coverage on PDL BioPharma (NASDAQ: PDLI) with a Neutral. PT $6.50.

For an analyst ratings summary and ratings history on PDL BioPharma click here. For more ratings news on PDL BioPharma click here.

Shares of PDL BioPharma closed at $7.83 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Credit Suisse

Add Your Comment